Dyne Therapeutics Inc.

NASDAQ: DYN · Real-Time Price · USD
12.09
-0.16 (-1.31%)
At close: Aug 20, 2025, 9:46 AM

Dyne Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-412.89M -367.13M -317.42M -294.51M -257.6M -257.4M -235.94M -208.13M -189.3M -176.7M -168.1M -181.06M -182.25M -159.91M -149.29M -126.15M -97.49M -76.52M
Depreciation & Amortization
2.46M 2.36M 2.24M 1.79M 1.78M 1.81M 1.84M 1.68M 1.64M 1.67M 1.68M 1.62M 1.49M 1.27M 1.09M 964K 879K 788K
Stock-Based Compensation
42.77M 38.98M 45.86M 41.12M 37.25M 35.26M 19.97M 18.07M 17.02M 15.31M 15.18M 17.36M 17.17M 18.38M 17.54M 15.74M 14.34M 10.18M
Other Working Capital
-3.33M -1.47M -6.47M 1.74M -3.98M 4.72M 3.34M -271K 687K 9.94M -4.14M 6.66M 16.87M -20.25M -4.45M -19.1M -25.34M -3M
Other Non-Cash Items
-426K -3.1M -2.47M -2.76M -1.73M -339K -341K 826K 171K 1.07M 2.58M 1.61M 2.09M 937K -746K 36K 319K 497K
Deferred Income Tax
n/a n/a n/a 727K 362K n/a n/a -727K -362K n/a n/a 745K 1.44M 2.1M 2.59M 1.85M 1.16M 504K
Change in Working Capital
9.09M 9.73M -19.49M 11.12M 1.44M 1.4M 26.31M 5.93M -3.72M 8.45M -5.38M 6.8M 23M -14.69M 9.26M -3.98M -15.66M 6.94M
Operating Cash Flow
-359.56M -319.73M -292.37M -243.04M -219.01M -219.79M -188.16M -182.34M -174.55M -149.81M -153.65M -152.52M -136.67M -151.91M -119.56M -111.53M -96.45M -57.61M
Capital Expenditures
-2.37M -3.17M -2.38M -1.38M -1.3M -690K -729K -1.17M -1.89M -1.9M -3.07M -4.54M -4.53M -5.01M -3.62M -2.35M -1.63M -959K
Cash Acquisitions
n/a n/a n/a 7.47K -5.52K -23K n/a 26.53K -13.03K 4.46K 11.46K -14.54K 38K 38K 8K n/a n/a n/a
Purchase of Investments
-216.66M -202.03M -317.44M -264.71M -217.25M -208.94M -44.24M -70.73M -66.33M -82.54M -121.18M -123.23M -169.69M -159.86M -236.72M -252.71M -201.06M -176.69M
Sales Maturities Of Investments
191.83M 182.41M 115.74M 104.24M 88.92M 86.06M 128.3M 148.24M 183.4M 200.83M 211.44M 195.49M 187.45M 153.22M 102.45M 72.18M 22.5M 3.82M
Other Investing Acitivies
14K n/a -179.65K -210.12K -197.13K -179.65K -23K -26.53K 13.03K 18.7M 18.69M 18.72M 18.66M -45.66K -144.03K -180.53K -178.56K -172.87K
Investing Cash Flow
-27.18M -22.78M -204.08M -161.87M -129.65M -123.59M 83.31M 76.35M 115.19M 116.4M 87.2M 67.73M 13.22M -11.65M -137.89M -182.88M -180.19M -173.82M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -10M -10M -10M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
123.01M 26.52M 36.84M 33.36M 15.8M 12.28M 1.95M 2.15M 1.76M 1.1M 529K 276K 663K 589K 584K 501K -382K -394K
Financial Cash Flow
263.66M 542.75M 809.89M 806.41M 788.85M 433.89M 54.32M 91.38M 90.99M 66.19M 37.39M 276K 663K 589K 157.82M 146.54M 526.04M 526.03M
Net Cash Flow
-123.08M 200.24M 313.44M 401.5M 440.19M 90.53M -50.52M -14.61M 31.64M 32.77M -29.05M -84.52M -122.78M -162.97M -99.63M -147.87M 249.4M 294.59M
Free Cash Flow
-361.93M -322.89M -294.75M -244.42M -220.31M -220.48M -188.89M -183.51M -176.43M -151.71M -156.71M -157.06M -141.2M -156.92M -123.18M -113.88M -98.08M -58.57M